Patients value progression-free survival more than providers

An interesting paper from my colleagues at Precision in Medical Decision Making looks at how patients, physicians and nurses value different treatment attributes related to survival and treatment toxicity. The authors surveyed patients, oncologists, and oncology nurses using a combined conjoint analysis and discrete choice experiment survey approach. They found that: Virtually all patients preferred…